Myocardial hypertrophy in chronic renal failure: A multifactorial, reversible alteration

Contributions to Nephrology

Volumn 119, Issue , 1996, Pages 135-140

  Cannella, Giuseppe ^a   Paoletti, Ernesto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; PROGNOSIS;

EID: 0029687171     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (14)

1. Messerli FH: Pathophysiology of left ventricular hypertrophy; in Cruickshank KJM, Messerli FH (eds): Left Ventricular Hypertrophy and Its Regression. London, Science Press, 1992, pp 13-20.
2. Frohlich ED, Apstein C, Chobanian AV, et al: The heart in hypertension. N Engl J Med 1992;327:998-1008.
3. Dzau VJ: Autocrine and paracrine mechanisms in the pathophysiology of heart failure. Am J Cardiol 1992;70:4C-11C.
4. Ollivier JP, Bouchet VA: Prospects for cardioreparation. Am J Cardiol 1992;70:27C-36C.
5. Cruickshank JM, Lewis J, Moore V, Dodd C: Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85-90.
6. Pickering TG: Ambulatory Monitoring and Blood Pressure Variability. London Science Press, 1991.
7. Wei JY: Age and the cardiovascular system. N Engl J Med 1992;327:1735-1739.
8. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL: Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786-2796.
9. Alderman MH: Blood pressure management: Individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993;119:329-335.
10. London GM, Fabiani F: Left ventricular dysfunction in end-stage renal disease: Echocardiographic insights; in Parfrey PS, Harnett JD (eds): Cardiac Dysfunction in Chronic Uremia. Basel Kluwer, 1992, pp 117-137.
11. Amann K, Mall G, Ritz E: Myocardial interstitial fibrosis in uraemia: Is it relevant? Nephrol Dial Transplant 1994;9:127-128.
12. Cannella G, Paoletti E, Delfino R, Peloso GC, Molinari S, Traverso GB: Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993;44:881-886.
13. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel K: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992;19:453-459.
14. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286-290.